Alma Fulurija
University of Western Australia
Telethon Kids Institute

Back to the future: Lessons from early twentieth century scarlet fever outbreaks for modern vaccine development
Josh Osowicki (Murdoch Children’s Research Institute)

Development of a Peptide-based vaccine to prevent rheumatic heart disease
Michael Good (Griffith University)

Facilitating Strep A Vaccine Development for Aotearoa New Zealand
Nikki Moreland (University of Auckland)

Platform for the recombinant production of group A streptococcus gylcoconjugate vaccines
Helge Dorfmuller (University of Dundee)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
Manisha Pandey (University of Griffith)